Showing results (41-50 of 129) with videos related to

Sort By:
Pageof 13
Antimicrobial Agents and Chemotherapy|September 22, 2010
Susceptibility of treatment-naive hepatitis C virus (HCV) clinical isolates to HCV protease inhibitorsAndrew Bae, Siu-Chi Sun, Xiaoping Qi, et al.
Virology|November 3, 2004
Conserved residues in the coiled-coil pocket of human immunodeficiency virus type 1 gp41 are essential for viral replication and interhelical interactionHongmei Mo, Alex K Konstantinidis, Kent D Stewart, et al.
Elife|September 4, 2019
Adaptation of hepatitis C virus to interferon lambda polymorphism across multiple viral genotypesNimisha Chaturvedi, Evguenia S Svarovskaia, Hongmei Mo, et al.
Gastroenterology|September 25, 2012
Development of robust hepatitis C virus genotype 4 subgenomic repliconsBetty Peng, Mei Yu, Simin Xu, et al.
Virology|November 28, 2017
Establishment of robust HCV genotype 4d, 5a, and 6a replicon systemsGregory Camus, Simin Xu, Bin Han, et al.
Antimicrobial Agents and Chemotherapy|June 20, 2007
In vitro selection and characterization of human immunodeficiency virus type 2 with decreased susceptibility to lopinavirSherie Masse, Xiaozhi Lu, Tatyana Dekhtyar, et al.
Virology|November 22, 2011
An adaptive mutation in NS2 is essential for efficient production of infectious 1b/2a chimeric hepatitis C virus in cell cultureKatie Chan, Guofeng Cheng, Rudolf K F Beran, et al.
Hepatology (Baltimore, Md.)|June 23, 2015
Hepatitis C virus drug resistance-associated substitutions: State of the art summaryErik Lontok, Patrick Harrington, Anita Howe, et al.
Bioscience Reports|May 23, 2020
Development of a novel prognostic signature for predicting the overall survival of bladder cancer patientsHuamei Tang, Lijuan Kan, Tong Ou, et al.
Lancet (London, England)|November 12, 2013
Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trialEric Lawitz, Fred F Poordad, Phillip S Pang, et al.
Pageof 13